A Treatment for Graves’ Disease Produced Promising Results in a Phase 1 Trial
Source: Pixabay

A Treatment for Graves’ Disease Produced Promising Results in a Phase 1 Trial

  A biotechnology company called Apitope is developing an innovative new immunotherapy treatment for a range of autoimmune diseases. A press release by the company that can be found here…

Continue Reading A Treatment for Graves’ Disease Produced Promising Results in a Phase 1 Trial
Recent Surveys Show What Patients Really Think About Their Standard of Care
Source: Pixabay

Recent Surveys Show What Patients Really Think About Their Standard of Care

An organisation called PatientsLikeMe that helps to represent patients to governments and pharmaceutical companies has published a press release about the results of two recent studies designed to define and…

Continue Reading Recent Surveys Show What Patients Really Think About Their Standard of Care
When Life Gave Her Multiple Sclerosis, She Started a Support Group
source: pixabay.com

When Life Gave Her Multiple Sclerosis, She Started a Support Group

Donna Keck has multiple sclerosis (MS). She's 61-years-old and has lived a life full of health complications, reports Chicago Tribune. Nevertheless, Keck battled through these challenges and eventually founded a grounded…

Continue Reading When Life Gave Her Multiple Sclerosis, She Started a Support Group
Sun Exposure In Adulthood Can Help Prevent Multiple Sclerosis in Women, Study Says
Source: Pixabay

Sun Exposure In Adulthood Can Help Prevent Multiple Sclerosis in Women, Study Says

According to a story from cbc.ca, a recent study suggests that the benefits of summertime sun exposure may be more effective at preventing multiple sclerosis symptoms than previously understood. Prior…

Continue Reading Sun Exposure In Adulthood Can Help Prevent Multiple Sclerosis in Women, Study Says
This Cannabis Research Company Just Received A License to Grow Cannabis For Treatment Development
Source: www.pixabay.com

This Cannabis Research Company Just Received A License to Grow Cannabis For Treatment Development

Just recently, MMJ International Holdings announced that MMJ Bioscience has received proper Canadian licensing to grow cannabis specifically to develop cannabinoid medicines to treat patients battling multiple sclerosis and Huntington's…

Continue Reading This Cannabis Research Company Just Received A License to Grow Cannabis For Treatment Development
Patient Organizations Are Starting to Risk Their Financial Ties to Big Pharma by Opposing High Drug Prices
source: pixabay.com

Patient Organizations Are Starting to Risk Their Financial Ties to Big Pharma by Opposing High Drug Prices

According to a story from Xconomy National, some patient advocacy organizations are beginning to speak out about exorbitantly high drug prices despite the fact that many of them receive funding…

Continue Reading Patient Organizations Are Starting to Risk Their Financial Ties to Big Pharma by Opposing High Drug Prices
Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities
source: pixabay.com

Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities

According to a story from The Independent, Britain's disability welfare program is coming under fire for its Personal Independent Payment (PIP) assessments. Statistical measures suggest that these assessments are taking…

Continue Reading Personal Independent Payment Assessments Are an Excuse to Strip Assistance Away From People With Disabilities
New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients
Source: Pixabay

New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients

Novartis and Pear Therapeutics have joined forces to develop digital therapeutic software applications to treat patients with schizophrenia and multiple sclerosis, reports World Pharma News. Novartis is known for the…

Continue Reading New Digital Therapies Developed For Schizophrenia and Multiple Sclerosis Patients
For the First Time Ever Scientists Can See Myelin Patterns Form, and It’s a Big Deal for MS Research
Source: Pixabay

For the First Time Ever Scientists Can See Myelin Patterns Form, and It’s a Big Deal for MS Research

If you or someone you love has multiple sclerosis, you probably know a bit about myelin. The human body needs to protect its crucial nerve cells, so it surrounds them…

Continue Reading For the First Time Ever Scientists Can See Myelin Patterns Form, and It’s a Big Deal for MS Research
Multiple Sclerosis Treatment Creates Potential Complications for Pregnancy
Source: Pixabay

Multiple Sclerosis Treatment Creates Potential Complications for Pregnancy

A new study has revealed several complications of a multiple sclerosis treatment. The studies illuminate difficulties surrounding a powerful drug treatment and potential pregnancies. Keep reading to learn more about the…

Continue Reading Multiple Sclerosis Treatment Creates Potential Complications for Pregnancy
Multiple Rare Disease Drugs Just Got Limited Coverage in British Columbia
source: pixabay.com

Multiple Rare Disease Drugs Just Got Limited Coverage in British Columbia

According to a story from the Vancouver Sun, five rare disease drugs just received coverage in British Columbia. The funding comes from savings accumulated thanks to a recent agreement that…

Continue Reading Multiple Rare Disease Drugs Just Got Limited Coverage in British Columbia
New Technology Developed Described As “Spotify For Chemistry”
Source: Pixabay

New Technology Developed Described As “Spotify For Chemistry”

University of Glasgow scientists might have just come across an incredible new approach to providing patients with pharmaceutical medications on demand, reported first by International Business Times. This new technology…

Continue Reading New Technology Developed Described As “Spotify For Chemistry”
NHS Inefficiency and Possible Funding Cuts Are Depriving Multiple Sclerosis Patients of Timely Care
source: pixabay.com

NHS Inefficiency and Possible Funding Cuts Are Depriving Multiple Sclerosis Patients of Timely Care

According to a story from Independent, cumbersome delays and possible funding cuts are severely hampering England's National Health Service (NHS). These delays are proving very costly for patients with long…

Continue Reading NHS Inefficiency and Possible Funding Cuts Are Depriving Multiple Sclerosis Patients of Timely Care
Close Menu